Indonesia resumes use of AstraZeneca's COVID-19 vaccine

Indonesia resumes use of AstraZeneca's COVID-19 vaccine
In this March 8, 2021, photo released by Indonesian Presidential Palace, workers unload containers containing AstraZeneca COVID-19 vaccine upon its arrival at Soekarno-Hatta International Airport in Tangerang on the outskirts of Jakarta, Indonesia. Indonesia on Friday, March 19, 2021 cleared the AstraZeneca vaccine for use again after the European Union's drug regulator said the vaccine didn't increase the overall incidence of blood clots. (Indonesian President Palace via AP)

Indonesia on Friday cleared the AstraZeneca vaccine for use again after the European Union's drug regulator said the vaccine didn't increase the overall incidence of blood clots.

Southeast Asia's biggest economy delayed the rollout of the COVID-19 vaccine after more than a dozen countries in Europe suspended the vaccine due to concerns of some people who received the vaccine developing blood clots.

"The benefits of using the COVID-19 vaccine AstraZeneca outweigh the possible risks, so that we can start to use it," Indonesia's Food and Drug Authority said in its announcement.

Previously the World Health Organization said it saw no evidence the vaccine was to blame for the clots.

The Indonesian agency said the risk of death from COVID-19 was much greater, "Therefore, the community still has to get vaccination against COVID-19 according to the designated schedule."

Indonesia has received 1.1 million doses of the AstraZeneca vaccine on March 8, through COVAX—a multilateral effort seeking to ensure equitable global access to COVID-19 vaccination—with another 10 million more expected next month.

Indonesia resumes use of AstraZeneca's COVID-19 vaccine
In this photo released by Indonesian Presidential Palace, a worker attaches a sticker on a container containing AstraZeneca COVID-19 vaccine upon its arrival at Soekarno-Hatta International Airport in Tangerang on the outskirts of Jakarta, Indonesia March 8, 2021 . Indonesia on Friday, March 19, 2021 cleared the AstraZeneca vaccine for use again after the European Union's drug regulator said the vaccine didn't increase the overall incidence of blood clots. (Indonesian President Palace via AP)

The AstraZeneca vaccine is the second to arrive in Indonesia after the one made by Chinese biopharmaceutical company Sinovac.

Indonesia aims to inoculate more than 181 million of its 270 million people by March 2022 as part of a free vaccination drive that began in January.


Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

© 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Citation: Indonesia resumes use of AstraZeneca's COVID-19 vaccine (2021, March 19) retrieved 7 May 2021 from https://medicalxpress.com/news/2021-03-indonesia-resumes-astrazeneca-covid-vaccine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments